Arcutis Biotherapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ARQT for the last quarter is 13.53 M USD, and it's 64.51% lower compared to the previous quarter. The net income of Q4 23 is -66.28 M USD.